Wednesday, July 8, 2026

pharma · Weight Loss · Adrenomyeloneuropathy Form (AMN) of X-linked Adrenoleukodystrophy (X-ALD) · VKTX

Viking Therapeutics

Viking Therapeutics trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.

San Diego, USA HQ
2012 Founded
60 Employees
Public company Type
VKTX · NYSE Ticker
Company details
Intelligence · Clinical Trials

Viking Therapeutics clinical trials

Registry index of 9 ClinicalTrials.gov studies linked to Viking Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Viking Therapeutics trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

6 updates

Latest clinical program signals indexed for Viking Therapeutics.

  1. VK2809 — Phase 2

    Clinical update
  2. VK0214 — Phase 1

    Clinical update
  3. Placebo — Phase 2

    Clinical update
  4. VK2735 — Phase 3

    Clinical update
  5. VK2809 — Phase 2

    Clinical update
  6. VK5211 — Phase 2

    Clinical update

Trial registry

9 studies